Data protection Impressum

Newsroom

Inergio has successfully delivered its first fuel cell power units to customers in Europe and North America, marking a key milestone in its expansion. With increasing demand for its modular and fuel-flexible energy solutions, the company is scaling up production to meet growing off-grid power needs.

Cleantech Inergio delivers its first fuel cell power units to customers

4 February 2025

The Swiss Institute of Bioinformatics has inaugurated the Centre for Pathogen Bioinformatics in Bern, a state-of-the-art facility dedicated to strengthening genomic surveillance of infectious diseases.

The Centre for Pathogen Bioinformatics was inaugurated in Bern

4 February 2025

The Lausanne University Hospital (CHUV) has secured market authorization from Swissmedic to produce a fecal microbiota transplant (FMT) medication, making it the first accredited center in Switzerland to manufacture this treatment under strict pharmaceutical standards. This breakthrough provides an effective solution for patients suffering from recurrent Clostridioides difficile infections, a debilitating condition characterized by repeated digestive blowouts and severe discomfort.

CHUV becomes first Swiss hospital to produce gut-balancing medication

29 January 2025

The Human Lean Diagnostics (HLD) innovation cluster in Neuchâtel is preparing to welcome its first tenants in June 2025. Developed in collaboration with Microcity, the cluster is dedicated to accelerating medical diagnostics innovation by providing state-of-the-art infrastructure, fostering collaboration between industry and academia, and strengthening Switzerland’s position in health technology.

Neuchâtel’s Human Lean Diagnostics cluster is set to welcome its first tenants

29 January 2025

Voltiris has raised CHF 4.8 million in seed financing to advance its innovative solar energy solutions for greenhouses. Co-led by EquityPitcher Ventures and 3M Ventures, the funding supports the commercialization of its proprietary spectral filtering technology across Europe.

Voltiris secures CHF 4.8 million to transform solar energy use in greenhouses

28 January 2025

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (January 2025)

28 January 2025

TheraMe!, a Lausanne-based medtech, is transforming cancer treatment by partnering with CSEM to develop an automated, microfluidic-based instrument. This breakthrough technology enables personalized drug screening on live tumor samples, providing cancer patients with tailored therapy recommendations before treatment begins.

CSEM and TheraMe! transform cancer therapy with personalized drug screening technology

28 January 2025

Geneva-based Transmutex has been awarded USD 4.2 million from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) as part of the NEWTON program. The funding will support a project at Los Alamos to develop technologies that transform long-lived radioactive waste into shorter-lived isotopes, addressing a critical challenge in nuclear waste management.

Transmutex secures USD 4.2 million for the transmutation of nuclear waste

27 January 2025

Fribourg-based company Builtronics is making strides in autonomous and remotely operated machinery, targeting the agriculture and construction industries. With significant support from local institutions, the company’s cutting-edge technology is paving the way for safer and more efficient solutions.

Fribourg’s Builtronics pioneers autonomous solutions in agriculture and construction

27 January 2025

EPFL Innovation Park biotech company AB2 Bio has signed an option and licensing agreement with Japan-based Nippon Shinyaku to advance Tadekinig alfa, a novel treatment for Primary Monogenic IL-18 driven Hyperinflammatory Syndrome. The deal includes up to USD 36 million in early payments and milestone-based funding of up to USD 650 million.

AB2 Bio secures USD 650 million partnership with Nippon Shinyaku for rare disease therapy

27 January 2025

1 … 10 11 12 13 14 15 16 17 18 … 143